Delivery Order SPE2DE24DA017-SPE2D626F02T9
Award Date 12/10/25
Potential Completion Date 12/15/25
Potential Value $6.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Naples, FL 34108, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Arthrex Inc., a Naples, Florida-based manufacturer of minimally invasive orthopedic medical technologies and surgical instruments, was awarded a fixed-price delivery order valued at $22,423.50 for an ACP Max PRP System (Out of US/Europe) on December 9, 2025, with an ultimate completion date of December 12, 2025. The contract, which carries no set-aside designation, is funded through the Defense Logistics Agency's Medical Supply Chain and will be performed at Arthrex's facility in Naples,...
- Arthrex Inc., a Naples, Florida-based manufacturer of minimally invasive orthopedic medical technologies, has been awarded a delivery order valued at $2,690.82 for the ACP MAX PRP System (OUS/EU) by the Defense Logistics Agency's Medical Supply Chain. This fixed-price delivery order with economic price adjustment is scheduled for completion by December 8, 2025, and represents work to be performed at Arthrex's Naples, Florida facility. The award carries no set-aside designation, reflecting the...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $3,029.40 on August 27, 2025, for the ACP MAX PRP System with ACDA (autologous conditioned plasma). This fixed-price delivery order with economic price adjustment is scheduled for completion by September 2, 2025, and represents performance under Arthrex's larger indefinite delivery contract with the Defense Logistics Agency's Medical Supply Chain. The order...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $14,503.50 on July 11, 2025, for the ACP MAX PRP System with ACDA. This fixed-price delivery order with economic price adjustment was issued under the Defense Logistics Agency's Medical Supply Chain and carries an ultimate completion date of July 16, 2025. The award represents work to be performed in Naples, Florida, and was made without a...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, received a $52,879.14 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, for an ACP MAX PRP System with ACDA technology. This delivery order represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) valued at $471 million and running through September 1, 2029. The contract carries no set-aside designation, reflecting Arthrex's...
- Arthrex Inc., a leading global provider of minimally invasive orthopedic medical technologies based in Naples, Florida, has been awarded a delivery order valued at $1,817.64 for an ACP MAX PRP System with ACDA under a Defense Logistics Agency Medical Supply Chain contract. The award, announced on August 29, 2025, is a fixed-price delivery order with economic price adjustment provisions and is set to be completed by September 4, 2025. This delivery order falls under Arthrex's larger Indefinite...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, received a delivery order valued at $1,211.76 from the Defense Logistics Agency's Medical Supply Chain on June 6, 2025. The order, designated as contract 4568471533 for an ACP MAX PRP System with ACDA (Autologous Conditioned Plasma with Advanced Concentrated Data Analysis), is structured as a fixed-price delivery order with economic price adjustment provisions and carries a completion date of June...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $3,111.90 on August 22, 2025, under a fixed-price contract with economic price adjustment provisions. The order, identified as 4569186034 and titled "ACP MAX PRP SYSTEM (W/ ACDA)," is scheduled for completion by August 27, 2025, with performance to be executed in Naples, Florida. This delivery order was issued without a set-aside designation, reflecting...
- Arthrex Inc., a Naples, Florida-based manufacturer of minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $10,393.29 for the Arthrex ACP Double Syringe System on December 10, 2025, with an ultimate completion date of December 15, 2025. This fixed-price delivery order with economic price adjustment falls under a larger single-award Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply Chain, valued at $471 million...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, received a $1,817.64 delivery order from the Defense Logistics Agency's Medical Supply Chain on August 13, 2025, for an ACP MAX PRP (Autologous Conditioned Plasma Maximum Platelet-Rich Plasma) System with Autologous Conditioned Plasma technology. This fixed-price contract with economic price adjustment provisions is set to conclude by August 18, 2025, and represents a task order under Arthrex's larger Indefinite...